On January 31, 2020, the Secretary of the Department of Health and Human Services (HHS) declared a public health emergency (PHE) throughout the United States due to the COVID-19 outbreak. On March 13, 2020, HHS authorized many waivers and modifications regarding Medicare Part B and DMEPOS claims to help prevent gaps in access to care for patients affected by the PHE. Please see below for some waivers and modifications to Medicare Part B and DMEPOS claims that may pertain to your pharmacy if you are a DMEPOS supplier.
- DMEPOS Mini-Series #5 – Surgical Dressings - September 22, 2022
- Trudhesa™ Nasal Spray for the Treatment of Migraines - September 20, 2022
- DMEPOS Mini-Series #4 – Urological Supplies: Intermittent Catheters - August 16, 2022